| DIRECT COMPETITOR COMPARISON | |
| NKTR | ADLR | AMGN | ENZN | Industry | | Market Cap: | 811.75M | 69.96M | 57.03B | 441.37M | 74.33M | | Employees: | 338 | 128 | 16,700 | 351 | 43 | | Qtrly Rev Growth (yoy): | -52.30% | 10.10% | -1.60% | -8.60% | 3.00% | | Revenue (ttm): | 61.28M | 32.82M | 14.58B | 188.84M | 17.49M | | Gross Margin (ttm): | -134.28% | -46.70% | 84.99% | 73.98% | 63.53% | | EBITDA (ttm): | -110.67M | -50.14M | 6.71B | 23.42M | -6.12M | | Oper Margins (ttm): | -205.01% | -157.95% | 38.71% | 2.26% | -3.79% | | Net Income (ttm): | -18.06M | -56.16M | 4.74B | 781.00K | N/A | | EPS (ttm): | -0.195 | -1.213 | 4.585 | 0.017 | -0.19 | | P/E (ttm): | N/A | N/A | 12.29 | 571.18 | 15.29 | | PEG (5 yr expected): | N/A | N/A | 1.31 | N/A | 1.28 | | P/S (ttm): | 13.10 | 2.10 | 3.92 | 2.45 | 3.39 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.35 | -0.27% | 57.03B | 12.29 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 46.94 | 0.04% | 13.57B | 15.71 | | Genzyme Corp. | GENZ | 50.70 | -0.72% | 13.45B | 28.91 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.11 | -0.97% | 41.50B | 17.83 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.78 | -0.34% | 8.88B | 1015.92 | | Teva Pharmaceutical Industries Limited | TEVA | 52.79 | -0.17% | 46.51B | 48.30 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.09 | 0.35% | 3.94B | 19.12 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.83 | -1.00% | 2.94B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.87 | -0.78% | 5.46B | 109.63 | | Pfizer Inc. | PFE | 18.17 | -0.44% | 146.62B | 15.09 | | Johnson & Johnson | JNJ | 62.84 | -0.08% | 173.38B | 13.72 | | GlaxoSmithKline plc | GSK | 41.47 | -1.87% | 105.13B | 13.17 | | Sanofi-Aventis | SNY | 37.96 | -1.22% | 99.12B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.60 | 0.40% | 126.28B | 16.65 | | RHHBY.PK | 40.92 | -1.30% | N/A | N/A | | AstraZeneca plc | AZN | 44.83 | -1.02% | 65.00B | 9.00 | | Abbott Laboratories | ABT | 54.49 | 0.76% | 84.28B | 14.76 | | Bristol-Myers Squibb Co. | BMY | 25.31 | -0.28% | 50.14B | 13.09 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | AMGN | | Amgen Highlights Data to be Presented at ASH
Mon 8:51am -
PR Newswire | | • | AMGN | | The Comeback Kids: The Interviews
Mon 5:01am -
at SmartMoney.com | | • | AMGN | | Soft-talking revolutionary
Sun, Nov 29 -
at FT.com | | • | AMGN | | 8 HealthCare Stocks With 3%+ Dividends
Sun, Nov 29 -
at Seeking Alpha | | • | AMGN | | Less Toxic Monoclonal Antibodies And Increased Patent Protection For Biologics Creates Multiple Positive Investment Scenarios In Biotechnology Sector
Sat, Nov 28 -
Wall Street Transcript | | • | AMGN | | This Big Winner Has Hit Its Prime
Fri, Nov 27 -
at Motley Fool | | • | ENZN | | Enzon Presents Data at 2009 EORTC Meeting
Thu, Nov 19 -
Business Wire | | • | ENZN | | Klarman, Whitman Are Sellers But Witmer Buys in Q3 2009
Wed, Nov 18 -
at Seeking Alpha | | • | ADLR | | Progenics: Are the Prospects That Bad?
Mon, Nov 16 -
at Seeking Alpha | | • | ENZN | | Enzon to Present Data at EORTC-NCI-AACR
Mon, Nov 16 -
Business Wire | | • | ENZN | | Unique Strategy Generates Big Returns for Baupost
Fri, Nov 13 -
Indie Research | | • | ENZN | | Watching Klarman's Latest Biotech Play
Thu, Nov 12 -
RealMoney by TheStreet.com | | • | ADLR | | Adolor Corporation Initiates Clinical Testing in Opioid Bowel Dysfunction Program
Thu, Nov 12 -
Business Wire | | • | ENZN | | ENZON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex
Thu, Nov 12 -
EDGAR Online | | • | ADLR | | Zacks #5 Rank Additions for Thursday
Thu, Nov 5 -
Zacks.com | | • | ADLR | | ADOLOR CORP Financials
Wed, Nov 4 -
EDGAR Online Financials | | • | ADLR | | ADOLOR CORP Files SEC form 10-Q, Quarterly Report
Fri, Oct 30 -
EDGAR Online | | • | ADLR | | Adolor Corp. Q3 2009 Earnings Conference Call
Thu, Oct 29 -
at Seeking Alpha | | • | ADLR | | Adolor Corporation Earnings Call scheduled for 8:45 am ET today
Thu, Oct 29 -
CCBN | | | All Headlines for these symbols... |
|
|
|
0.34% Nasdaq 
Competitors
